HealthDay News — For pediatric-onset treatment-resistant epilepsy, cannabinoids are effective as an adjunctive treatment for reducing seizure frequency by 50% or more, according to a review published online in the Journal of Neurology, Neurosurgery & Psychiatry.
Emily Stockings, PhD, from the National Drug and Alcohol Research Centre in Sydney, and colleagues reviewed the evidence for cannabinoids as adjunctive treatments for treatment-resistant epilepsy. Data were included from 6 randomized controlled trials and 30 observational studies
AgeVital has a full range of CBD products available for whatever situation you may need. VitalCBD Products range from traditional pills, to rapid action dissolving tablets, and even honey sticks and moisturisers. Not sure which is right for you? Give us a call or visit us in store and ask to talk to our pharmacist to find out what’s right for you!
If you know what you want call or visit in store to purchase any of our Vital CBD products – 1-888-388-7237